Nelson's Pediatric Antimicrobial Therapy

Nelson's Pediatric Antimicrobial Therapy
28th Ed.
2022 © American Academy of Pediatrics
John S. Bradley MD
John S. Bradley, MD
ISBN-10: 1-61002-564-4 / ISBN-13: 978-1-61002-564-5
eISBN-10: 1-61002-565-2 / eISBN-13: 978-1-61002-565-2
ISSN: 2164-9278 (print) / ISSN: 2164-9286 (electronic)
Pediatrics, Infectious Diseases, Nursing

Description

Completely updated and revised, the 28th edition of this best-selling reference provides instant access to the latest recommendations for the treatment of infectious diseases in children. For each disease, the authors provide a commentary to help select the best of all antimicrobial choices. Drug descriptions cover all antimicrobial agents available today and include complete information about dosing regimens.

Topics include:

  • • Antimicrobial Therapy by Clinical Syndromes
  • • Antimicrobial Therapy for Neonates
  • • Choosing Among
  • • Antibiotics
  • • Antifungal Agents
  • • Antiviral Agents
  • • Antiparasitic Agents
  • • Oral Step-down Therapy for Serious Infections
  • • Prevention of Symptomatic Infection
  • • Approach to Antibiotic Allergies
  • • Antibiotic Stewardship

New in the 28th Edition

  • • Updated recommendations on acute hematogenous osteomyelitis, based on newly published guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America, including information on a decrease in the incidence of MRSA infections, allowing the recommendation of cefazolin, again, in empiric therapy for most pediatric bone infections
  • • Updated recommendations on influenza treatment and prophylaxis, reflecting American Academy of Pediatrics guidance for 2021–2022
  • • Ceftazidime/avibactam now preferred over fluoroquinolones for treatment of Klebsiella pneumoniae carbapenemase–producing enteric bacilli, if susceptible
  • • Cefiderocol, a new iron-binding siderophore cephalosporin class, recently approved in adults for treatment of many drug-resistant pathogens, particularly Acinetobacter, Stenotrophomonas, and Pseudomonas; under study in children
  • • New dosing for Posaconazole suspension formulation
  • • New approaches to mucormycosis
  • • Added baloxavir for children 12+ years old

Doody's Reviews

Doody's Core Titles (DCT)
Specialty Score: 2.71 Health Sciences - General Medicine
Go to Doody's Review page

Quotes, Reviews or Testimonials

"This is an excellent reference for antimicrobial therapy. The new rating system for strength of recommendation and level of supporting evidence that is new to this edition is very useful and assists in the decision-making process in the clinical setting."

-- Judy Moreau, MD (Ochsner for Children) Doody's Review - a previous edition

"With an ever-increasing amount of literature becoming available for the treatment of pediatric infectious diseases, frequent updates of resources like this are necessary to keep providers informed about the most appropriate treatment."

-- Patricia Marshik, Pharm.D (University of New Mexico College of Pharmacy) Doody's Review - prior edition

Audience

Although written for practitioners in any specialty who may encounter patients with infectious diseases, the book is especially helpful for general pediatricians who, on a daily basis, care for children with infectious diseases.

Table of Contents


Similar Resources